rs140408058

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001199397.3(NEK1):​c.3285C>T​(p.Pro1095=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000634 in 1,609,494 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00039 ( 2 hom. )

Consequence

NEK1
NM_001199397.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.53
Variant links:
Genes affected
NEK1 (HGNC:7744): (NIMA related kinase 1) The protein encoded by this gene is a serine/threonine kinase involved in cell cycle regulation. The encoded protein is found in a centrosomal complex with FEZ1, a neuronal protein that plays a role in axonal development. Defects in this gene are a cause of polycystic kidney disease (PKD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 4-169406685-G-A is Benign according to our data. Variant chr4-169406685-G-A is described in ClinVar as [Benign]. Clinvar id is 457136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NEK1NM_001199397.3 linkuse as main transcriptc.3285C>T p.Pro1095= synonymous_variant 32/36 ENST00000507142.6 NP_001186326.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NEK1ENST00000507142.6 linkuse as main transcriptc.3285C>T p.Pro1095= synonymous_variant 32/361 NM_001199397.3 ENSP00000424757 A2Q96PY6-3

Frequencies

GnomAD3 genomes
AF:
0.00294
AC:
446
AN:
151922
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00105
AC:
259
AN:
246800
Hom.:
2
AF XY:
0.000821
AC XY:
110
AN XY:
133904
show subpopulations
Gnomad AFR exome
AF:
0.0110
Gnomad AMR exome
AF:
0.00190
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000332
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000116
Gnomad OTH exome
AF:
0.00118
GnomAD4 exome
AF:
0.000391
AC:
570
AN:
1457454
Hom.:
2
Cov.:
28
AF XY:
0.000352
AC XY:
255
AN XY:
725052
show subpopulations
Gnomad4 AFR exome
AF:
0.00976
Gnomad4 AMR exome
AF:
0.00183
Gnomad4 ASJ exome
AF:
0.000422
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000468
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000586
Gnomad4 OTH exome
AF:
0.00131
GnomAD4 genome
AF:
0.00296
AC:
450
AN:
152040
Hom.:
1
Cov.:
31
AF XY:
0.00279
AC XY:
207
AN XY:
74294
show subpopulations
Gnomad4 AFR
AF:
0.0101
Gnomad4 AMR
AF:
0.00105
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00145
Hom.:
0
Bravo
AF:
0.00326
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000165
EpiControl
AF:
0.000299

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesDec 28, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 30, 2018- -
Short-rib thoracic dysplasia 6 with or without polydactyly Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
NEK1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 01, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
1.2
DANN
Benign
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140408058; hg19: chr4-170327836; API